Terms: = Endocrine gland cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2
75 results:
1. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation.
Wang T; Zhang M; Khan M; Li J; Wu X; Ma T; Li Y
Biomed Pharmacother; 2024 Jan; 170():115956. PubMed ID: 38039759
[TBL] [Abstract] [Full Text] [Related]
2. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
Ran XM; Xiao H; Tang YX; Jin X; Tang X; Zhang J; Li H; Li YK; Tang ZZ
Sci Rep; 2023 Nov; 13(1):19474. PubMed ID: 37945610
[TBL] [Abstract] [Full Text] [Related]
3. CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention.
Wang Y; Chen X; Yang Y
Clin Transl Oncol; 2024 Mar; 26(3):584-596. PubMed ID: 37578652
[TBL] [Abstract] [Full Text] [Related]
4. A comparative study of [
Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
[TBL] [Abstract] [Full Text] [Related]
5. Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian cancer: Exacerbation by IL-6 and Attenuation by Resveratrol.
Vidoni C; Ferraresi A; Vallino L; Salwa A; Ha JH; Seca C; Garavaglia B; Dhanasekaran DN; Isidoro C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675246
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-suppressive miR-323a inhibits pancreatic cancer cell proliferation and glycolysis through targeting HK-2.
Wei Y; Wang M; Liang M; Liu L; Mo S; Zhang H; Chen Y; Li N
Pathol Int; 2022 Dec; 72(12):617-630. PubMed ID: 36416387
[TBL] [Abstract] [Full Text] [Related]
7. [
de Koster EJ; van Engen-van Grunsven ACH; Bussink J; Frielink C; de Geus-Oei LF; Kusters B; Peters H; Oyen WJG; Vriens D;
Mol Imaging Biol; 2023 Jun; 25(3):483-494. PubMed ID: 36253663
[TBL] [Abstract] [Full Text] [Related]
8. Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells.
Tian X; Liu D; Zuo X; Sun X; Wu M; Li X; Teng Y
J Ovarian Res; 2022 Aug; 15(1):92. PubMed ID: 35953860
[TBL] [Abstract] [Full Text] [Related]
9. miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/hk2 axis.
Tuo X; Zhou Y; Yang X; Ma S; Liu D; Zhang X; Hou H; Wang R; Li X; Zhao L
Pathol Res Pract; 2022 Sep; 237():154032. PubMed ID: 35914373
[TBL] [Abstract] [Full Text] [Related]
10. Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic cancer Through Upregulating Bmi1-UPF1-hk2 Pathway.
Wu S; Zhang H; Gao C; Chen J; Li H; Meng Z; Bai J; Shen Q; Wu H; Yin T
Cell Mol Gastroenterol Hepatol; 2022; 14(5):1146-1165. PubMed ID: 35863742
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on hk2 in Ovarian cancer.
Lu J; Zhen S; Tuo X; Chang S; Yang X; Zhou Y; Chen W; Zhao L; Li X
Technol Cancer Res Treat; 2022; 21():15330338221110668. PubMed ID: 35770296
[No Abstract] [Full Text] [Related]
12. HIF-1
Lyu Y; Zhang Y; Wang Y; Luo Y; Ding H; Li P; Ni G
J Immunol Res; 2022; 2022():6130806. PubMed ID: 35733918
[TBL] [Abstract] [Full Text] [Related]
13. MFAP2 aggravates tumor progression through activating FOXM1/β-catenin-mediated glycolysis in ovarian cancer.
Zhao LQ; Sun W; Zhang P; Gao W; Fang CY; Zheng AW
Kaohsiung J Med Sci; 2022 Aug; 38(8):772-780. PubMed ID: 35546486
[TBL] [Abstract] [Full Text] [Related]
14. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
[TBL] [Abstract] [Full Text] [Related]
15. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076
[TBL] [Abstract] [Full Text] [Related]
16. Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic cancer.
Ma Z; Li Z; Ma Z; Zhou Z; Zhuang H; Liu C; Huang B; Zou Y; Zheng Z; Yang L; Gong Y; Huang S; Zhou Q; Zhang C; Hou B
Biomed Res Int; 2021; 2021():9949272. PubMed ID: 34660806
[TBL] [Abstract] [Full Text] [Related]
17. Mechanistic Actions between
Nik Mohamed Kamal NNS; Abdul Aziz FA; Tan WN; Fauzi AN; Lim V
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207699
[TBL] [Abstract] [Full Text] [Related]
18. MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/hk2/PKM2 axis.
Yu T; Li G; Wang C; Gong G; Wang L; Li C; Chen Y; Wang X
RNA Biol; 2021 Dec; 18(12):2513-2530. PubMed ID: 34110962
[TBL] [Abstract] [Full Text] [Related]
19. An Experimentally Induced Mutation in the UBA Domain of p62 Changes the Sensitivity of Cisplatin by Up-Regulating hk2 Localisation on the Mitochondria and Increasing Mitophagy in A2780 Ovarian cancer Cells.
Yu S; Yan X; Tian R; Xu L; Zhao Y; Sun L; Su J
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924293
[TBL] [Abstract] [Full Text] [Related]
20. PGC1α Promotes Cisplatin Resistance in Ovarian cancer by Regulating the HSP70/hk2/VDAC1 Signaling Pathway.
Li Y; Kang J; Fu J; Luo H; Liu Y; Li Y; Sun L
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802591
[TBL] [Abstract] [Full Text] [Related]
[Next]
